Targeted inhibition of leukemia inhibitory factor (LIF)/lifr axis for the treatment of triple-negative breast cancer

Ended Project Grant Awarded Last action

Award ID
W81XWH1810015
Recipient
Awarding agency
Obligated
$960,000

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Originally
Place of performance
Schertz, TX 78154, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment COVID19. Targeted inhibition of leukemia inhibitory factor (LIF)/lifr axis for the treatment of triple-negative breast cancer $0
Original award $960,000

Quick answers

Who received award W81XWH1810015?

W81XWH1810015 was awarded to Evestra, Inc. by Medical Command (Department of the Army) on February 1, 2018.

How much is award W81XWH1810015 worth?

$960,000 has been obligated on W81XWH1810015.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award